Edwards Lifesciences (EW) Net Cash Flow Growth (5y) (2014 - 2026)
Edwards Lifesciences (EW) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Steris | 21.44 Bn | 21.00 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.34% |
| Dec 31, 2025 | 5.88% |
| Sep 30, 2025 | -46.72% |
| Jun 30, 2025 | -6.98% |
| Mar 31, 2025 | 17.18% |
| Dec 31, 2024 | -162.70% |
| Sep 30, 2024 | 35.24% |
| Jun 30, 2024 | 79.42% |
| Mar 31, 2024 | 85.23% |
| Dec 31, 2023 | 13.63% |
| Sep 30, 2023 | 62.63% |
| Jun 30, 2023 | 104.12% |
| Mar 31, 2023 | -23.51% |
| Dec 31, 2022 | -35.11% |
| Sep 30, 2022 | -20.55% |
| Jun 30, 2022 | 20.02% |
| Mar 31, 2022 | 27.61% |
| Dec 31, 2021 | -33.78% |
| Sep 30, 2021 | -6.69% |
| Jun 30, 2021 | 25.68% |